Back to search
FDAFDA · Food and drugs·Recall number D-0314-2024

Febuxostat Tablets, 40 mg, 30 Tablets (3 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-538-21, NDC Unit dose 60687-538-11

Published February 14, 2024 · Recall initiated: January 25, 2024

Summary

FDA records drug Class II recall D-0314-2024, published February 14, 2024 and initiated January 25, 2024. Recalling firm: Amerisource Health Services LLC; Status: Terminated; Reported quantity: 1,932 cartons; Lot: Lot # 1015033, exp. 06/30/2025; 1016409, exp. 08/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email if FEBUXOSTAT has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FEBUXOSTAT
Manufacturer
Amerisource Health Services LLC
Distributor
USA Nationwide
Lot
Lot # 1015033, exp. 06/30/2025; 1016409, exp. 08/31/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Febuxostat Tablets, 40 mg, 30 Tablets (3 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-538-21, NDC Unit dose 60687-538-11 recalled?

Yes. FDA published recall D-0314-2024 on February 14, 2024. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FEBUXOSTAT.